Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P A BUNN

Showing results (71-80 of 272) with videos related to

Pageof 28
Sort By:
Medical and Pediatric Oncology|January 11, 1991
Growth factors in lung cancer: possible etiologic role and clinical targetK Kelly, M A Kane, P A Bunn
International Journal of Radiation Oncology, Biology, Physics|August 11, 1991
Maximum tolerated dose for low-dose continuous infusion cisplatinM B Hazuka, P A Bunn, J Crowley
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|November 10, 2006
Anti-growth factor therapy for lung cancerD C Chan, M Geraci, P A Bunn
Neurology|January 1, 1973
Further observations on subacute denervation and mammalian motor nerve terminal functionP A Bunn, M Okamoto, W F Riker
Cancer Treatment Reports|April 1, 1979
The kinetics of Sézary cell productionS E Shackney, R Edelson, P A Bunn
Annals of Internal Medicine|October 29, 2010
Observations on tuberculosis control in a university hospitalC MUSCHENHEIM, P A BUNN, F S LANSDOWN
Seminars in Oncology|September 1, 1978
Central nervous system metastases in small cell bronchogenic carcinomaP A Bunn, J L Nugent, M J Matthews
Seminars in Oncology|September 1, 1986
Alpha interferon treatment of low-grade B-cell non-Hodgkin's lymphomas, cutaneous T-cell lymphomas, and chronic lymphocytic leukemiaK A Foon, M S Roth, P A Bunn
International Journal of Cancer. Supplement = Journal International Du Cancer. Supplement|January 1, 1987
Recombinant interferon alfa-2a, an active agent in advanced cutaneous T-cell lymphomasP A Bunn, D C Ihde, K A Foon
Cancer Treatment and Research|January 1, 1988
Interferon therapy for lymphoproliferative disordersM S Roth, P A Bunn, K A Foon
Pageof 28

Showing results (71-80 of 272) with videos related to

Sort By:
Pageof 28
Medical and Pediatric Oncology|January 11, 1991
Growth factors in lung cancer: possible etiologic role and clinical targetK Kelly, M A Kane, P A Bunn
International Journal of Radiation Oncology, Biology, Physics|August 11, 1991
Maximum tolerated dose for low-dose continuous infusion cisplatinM B Hazuka, P A Bunn, J Crowley
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|November 10, 2006
Anti-growth factor therapy for lung cancerD C Chan, M Geraci, P A Bunn
Neurology|January 1, 1973
Further observations on subacute denervation and mammalian motor nerve terminal functionP A Bunn, M Okamoto, W F Riker
Cancer Treatment Reports|April 1, 1979
The kinetics of Sézary cell productionS E Shackney, R Edelson, P A Bunn
Annals of Internal Medicine|October 29, 2010
Observations on tuberculosis control in a university hospitalC MUSCHENHEIM, P A BUNN, F S LANSDOWN
Seminars in Oncology|September 1, 1978
Central nervous system metastases in small cell bronchogenic carcinomaP A Bunn, J L Nugent, M J Matthews
Seminars in Oncology|September 1, 1986
Alpha interferon treatment of low-grade B-cell non-Hodgkin's lymphomas, cutaneous T-cell lymphomas, and chronic lymphocytic leukemiaK A Foon, M S Roth, P A Bunn
International Journal of Cancer. Supplement = Journal International Du Cancer. Supplement|January 1, 1987
Recombinant interferon alfa-2a, an active agent in advanced cutaneous T-cell lymphomasP A Bunn, D C Ihde, K A Foon
Cancer Treatment and Research|January 1, 1988
Interferon therapy for lymphoproliferative disordersM S Roth, P A Bunn, K A Foon
Pageof 28